Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use programKai Hübel, Nicolaus Kröger, Sebastian Theurich et al.|Bone Marrow Transplantation|2010Cited by 79
Differential impact of <i>IDH1</i>/<i>2</i> mutational subclasses on outcome in adult AML: results from a large multicenter studyJan Moritz Middeke, Christian Thiede, Klaus H. Metzeler et al.|Blood Advances|2021Cited by 44
Impact of <i>PTPN11</i> mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemiaSebastian Stasik, Jan‐Niklas Eckardt, Michael Krämer et al.|Blood Advances|2021Cited by 35